Seattle Genetics’ Adcetris receives FDA approval for peripheral T-cell lymphoma

pharmanewsdaily- November 18, 2018 0

Seattle Genetics' Adcetris, in combination with CHP chemotherapy, gains FDA approval for treating certain types of peripheral T-cell lymphoma. Seattle Genetics has announced that the ... Read More